- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bodal Chemicals' Board met to approve key decisions. The company reported consolidated financial results for the quarter, with revenue at Rs. 454.20 Cr and profit at Rs. 9.22 Cr.
The Board also approved re-appointments for Mr. Mayank K Mehta as Independent Director, Mr. Suresh J. Patel as Chairman & MD, and Mr. Bhavin S. Patel as Executive Director, all pending shareholder approval. New secretarial and statutory auditors were also appointed.
In a strategic move, the Board approved selling 7.86 acres of land at Unit 12 for a unit consuming chlorine byproduct, aiming for uninterrupted production and better financials. The Annual General Meeting is scheduled for September 26.